Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a world-leading precision oncology platform
company that specializes in the research and application of cancer molecular profiling. We provide early cancer screening,
diagnosis and treatment recommendations, continuous disease monitoring and care, and biopharma development services that
cover the entire spectrum of cancer management. The Company is committed to applying innovative genomics technology to
cancer-related diagnosis and treatment and to ultimately defeating cancer.